Journal article
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
- Abstract:
-
Eighty-five percent of multiple sclerosis cases begin with a discrete attack termed clinically isolated syndrome, but 37% of clinically isolated syndrome patients do not experience a relapse within 20 years of onset. Thus, the identification of biomarkers able to differentiate between individuals who are most likely to have a second clinical attack from those who remain in the clinically isolated syndrome stage is essential to apply a personalized medicine approach. We sought to identi...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, 1.2MB)
-
(Supplementary materials, 1.6MB)
-
- Publisher copy:
- 10.1093/braincomms/fcab084
Authors
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Brain Communications Journal website
- Volume:
- 3
- Issue:
- 2
- Article number:
- fcab084
- Publication date:
- 2021-04-19
- Acceptance date:
- 2021-03-19
- DOI:
- EISSN:
-
2632-1297
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1177224
- Local pid:
- pubs:1177224
- Deposit date:
- 2021-05-27
Terms of use
- Copyright holder:
- Probert et al.
- Copyright date:
- 2021
- Rights statement:
- Copyright The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record